Cyber Monday saleUp to 70% OFF
EEE

ELIXINOL WELLNESS LIMITED

No trades
See on Supercharts
Overview Financials News
Ideas
Discussions Seasonals

EXLDA trade ideas

Long trade on Elixinol Global (EXL)This trade truly is the epitome of risk:reward. If you look at Creso Pharma (CPH) in October-December of 2020, you will note EXL is mirroring similar price action. What this means, is that EXL is literally trading at all-time lows, and this takes into consideration the 2020 Covid Crash. I am currently in this trade with two (2) entries, one at $0.19 and another at $0.15. I will be holding this trade long term in anticipation of positive news regarding decriminalisation in the US, Canada, Europe, UK and subsequently Australia. Good luck traders. Manage your risk.
ASX:EXLLong
by MatthewMallet
(OTC: ELLXF) Sell Elixinol Global & Aurora CannabisHey Cannabis Investors! I recommended our paid members sell their Aurora Cannabis (NYSE: ACB) and Elixinol Global (OTC: ELLXF) holdings. I am no longer confident in either company’s ability to weather a sustained downturn. Aurora is struggling on all fronts. And Aurora founder Terry Booth recently left under a cloud of controversy (read more about the company’s troubles here: www.barrons.com). Elixinol is facing similar issues, and the company’s U.S. expansion has been a disappointment. I’m disappointed that these stocks have done so poorly. But I feel it’s best that we cut our losses. It’s possible that these companies will rebound. But I believe they no longer offer an attractive risk-reward proposition. Stay ahead of the masses, Seth Maniscalco Owner, Modern Wealth Management Founder, Crypto Wealth Coach Founder, Trading Resource Artificial Intelligence Network (T.R.A.I.N.) #NoMore925 #ProfitsOverPaychecks
EShort
by smaniscalco
Blame Canada for the Pot Stock CrashHappy 420! When legal recreational cannabis sales began in Canada on Oct 17, 2018, marijuana companies and investors were brimming with confidence... A large industrialized country had finally legalized marijuana. And with an adult population of nearly 30 million people, Canada would finally show the world just how big and lucrative the recreational marijuana industry could be... Aurora Cannabis . Canopy Growth. Aphria. Tilray . They’re all Canadian. And they’re among the biggest marijuana companies in the world... Their stocks were soaring. They were going to take over the world. First Canada. Then the USA. And then the rest of the globe... But what no one had counted on was an inept Canadian bureaucracy... Canada put Health Canada, the countries department of public health, in charge of regulating the Canadian marijuana industry... ...and Health Canada hasn’t been up to the task. Entering 2019, health Canada had more than 800 pending applications for processing, sales, and cultivation licenses. On average, it’s taking 341 days to approve licenses to sell marijuana... And the time it takes to approve cultivation licenses is anywhere from 6 months to a few years. It took Aphria almost 2 years just to get its upgrade of an existing facility approved... The failure to approve retail locations has depressed sales. And the failure to approve grow facilities has made it difficult to keep up with demand... It’s almost as if Health Canada wants the legal marijuana industry to go away... Canada’s marketing and advertising restrictions for marijuana aren’t helping matters either... Canada bans the use of mass advertising, sponsorships, endorsements, testimonials and promotions for Marijuana... It also prohibits communicating information about marijuana’s price or distribution... Canada also artificially restricted the size of the market by allowing only the sale of the flower and oils... These structural flaws have made it difficult for the legal, regulated cannabis industry to take off... In the 3rd quarter of last year the average price (to consumers) of legal marijuana was CA$10.23 per gram, according to Statistics Canada (which is run by the Canadian Government). Statistics Canada reports that the average price of black market marijuana was only CA$5.59... It’s no wonder the big legal marijuana companies in Canada are struggling... Health Canada’s bureaucrat quicksand, combined with its limits on products and marketing, has slowed growth and created a thriving black market... It’s also infected the larger marijuana industry. Every time a Canadian marijuana giant misses earnings or revenue estimates, stock prices for the entire sector plummet. And because pot stocks are dominated by retail investors (institutional investors are largely unable to invest in pot companies because pot is still illegal at the federal level in the US), prices can drop rapidly. Retail investors typically hold on to their investments for less time - and have a lower risk tolerance - than institutional investors... Canada’s approach is fundamentally unacceptable. Fortunately there are sign of progress. Health Canada is trying to speed up the review process for licenses. And the sale of edibles and other cannabis derivatives is expected to begin this month... But it’s going to take some time before the promise of the Canadian market becomes a reality... That doesn’t mean you shouldn’t invest in the big Canadian pot companies. It simply means you have to adjust your timeline for success... Now is a good time to buy because pot stocks are a bargain, especially considering how much the industry is going to grow... Over the course of the next few years, the cannabis market will reach incredible new heights. It won’t happen as quickly as you’d like. It will be a slow and steady March instead of a meteoric rise... But it will happen!!! And that means if you’re going to invest in pot stocks, you have to be in it for the long haul. There’s no shortcut to success. Buy now while you can still get bargain prices. And then hold. You’re investing in what could be a $66 billion global marijuana market by 2025... And these companies, and a few others I’ve picked, represent your best chance to capture a hit from that cone!!! Stay ahead of the masses, Seth Maniscalco Owner, Modern Wealth Management Founder, Crypto Wealth Coach Founder, T.R.A.I.N. #NoMore925 #ProfitsOverPaychecks
ELong
by smaniscalco
ASX:EXL - Bullish revenge in 2020? After forming a double top at the end of May last year, ASX:EXL has been bled down - dropping 90% (!!) from its all time highs. The bulls stepped in, providing some relief with 4 straight weeks of buying early this year. Can this be sustained? Here's why I'm bullish: Volume: High volume week, pushing the OBV above the 13EMA. "Volume precedes price", aka "Follow the money" Structure: Small inverse H/S on the daily, potentially forming a larger inverse H/S. Divergence: Confirmed histogram div, willy stupid, RSI making higher high. Weekly gap: >4% unaccounted for at the $4.5 price. Trend break. Zooming into the 1D chart My prediction is we range for the next month, filling in the VPVR void and providing opportunities to accumulate for astute traders. This range would give us a larger inverse H/S, providing the bullish spring needed to begin regaining some of that 90% drop from last year. Hit the LIKE button if you find my analysis valuable and want to support me. Follow to make sure you don't miss any future trade ideas.
ASX:EXLLong
by AndyTheKing
7
Going Green in the Land Down Under!!Hey Friends! Elixinol Global (OTC: ELLXF) primarily deals in hemp-based dietary supplements and skin care products. It also has a new medical marijuana brand called Nunyara... The company started out as Elixinol Australia. It was a first mover in the cannabis-infused food world and is now a top dog because of it... Hemp Foods Australia is the company’s legacy brand. It sells everything from hemp burgers to skin care products... But Elixinol really hit the big time when it expanded globally. Elixinol Japan and Elixinol USA were founded in 2014. And the company’s main expansion focus now is the United States. In anticipation of cannabis legalization in America, Elixinol has invested heavily in its U.S. subsidiary. It teamed up with RFI to create Infusion Strategies. The joint venture will develop hemp-infused food products for the American market... Those hemp-infused foods may be heading to a grocery store near you soon. Elixinol has worked out deals with Safeway Group and Albertsons, two major supermarket chains. Soon, Elixinol’s products could be found in as many as 1,000 food stores across America... It even has an $18 million agreement with Pet Releaf to sell CBD-infused pet products. Pet Releaf’s products are sold in more than 4,000 pet stores across America. Elixinol exclusively produces and supplies the USDA-certified organic hemp for Pet Releaf... In the late spring and early summer of 2019, Elixinol sold 12.8 million shares to raise $50 million. That money went straight into growing the company’s global reach, particularly in the United States... But how does hemp-infused food help fight Big Pharma??? Hemp has enormous nutritional value. It contains all nine essential amino acids. It also has boatloads of protein and fatty acids... Hemp could also potentially reduce your risk of heart disease. That’s the No. 1 killer of people regardless of age, sex or race worldwide. It also helps promote healthy weight loss and improves digestion... If there’s less going wrong with your body, it means fewer trips to the doctor and less money in Big Pharma's pockets!!! Stay ahead of the masses, Seth
ELong
by smaniscalco
EXL - ASX - 4Hr - BullishThe marijuana sector on the ASX has been showing some volume returning to the market. Time to long some stocks. Purely Technical analysis here.. Fibonacci tool range from the low where volume increased significantly to the high in May. price has pulled back to the 50% range 314MA seems to be showing some support with a few touches on the 4 hourly. awaiting buy signal on the 314 MA Price coincides with previous prices (blue line) If price breaks the 314MA, 0.5 retracement and the support from previous highs I have a SL @ $3.38 :) Happy Trading!
ASX:EXLLong
by jonnytren
$EXL - ELIXINOL GLOBAL - Hemp company with a decent chart.$EXL - ELIXINOL GLOBAL - Cannabis company with a decent chart. I've been following EXL for the last week or so after reading an article on them by an analyst who I quite like. ELIXINOL seems to have some good momentum in its business aggressively going after overseas markets. After a bit of a retrace entry conditions look good so have put in a bid. Would have liked to see more volume before entry but on the lower 15 minute chart there was a pretty good spike that broke out of its Bollinger Bands. RSI is around the mid 50's so looks like good value and a good time to take a punt for me. ABOUT ============= Elixinol Global Limited (“EXL”) (ASX:EXL; OTCQX:ELLXF) through its businesses has a global presence in the cannabis industry including hemp-derived CBD dietary supplements, hemp food and wellness products, as well as cultivation and manufacture of medicinal cannabis products. EXL’s businesses include: - Elixinol (hemp-derived CBD dietary supplements), which was founded in 2014, is a manufacturer and global distributor of industrial hemp based dietary supplement and skincare products, with operations based out of Colorado, USA. - Hemp Foods Australia (hemp-derived foods and skincare), which was founded in 1999, is a leading hemp food wholesaler, retailer, manufacturer and exporter of bulk and branded raw materials, and finished products. - Nunyara (pharmaceutical medical cannabis), which was founded in 2014 to participate in the emerging Australian medicinal cannabis market has applications pending for cultivation and manufacturing licences.
ASX:EXLLong
by zAngus